Labeler · US market

Ritedose Pharmaceuticals, LLC

Ritedose Pharmaceuticals, LLC is a US drug labeler with US FDA registrations covering 9 drug concepts (9 currently active) across 35 packages. It is currently the only active US supplier of 3 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes76204

Active drugs9

Registrations14 active / 14

Packages35

Sole supplier of3 drugs

Portfolio9 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Albuterol Sulfate solution	rx	4	9	SUPPLYING
Levalbuterol Hydrochloride solution	rx	3	9	SUPPLYING
Ipratropium Bromide And Albuterol Sulfate solution	rx	1	5	SUPPLYING
Ipratropium Bromide solution	rx	1	4	SUPPLYING
Arformoterol Tartrate Inhalation Solution solution	rx	1	3	SUPPLYING
Formoterol Fumarate Dihydrate solution	rx	1	2	SUPPLYING
Tobramycin solution	rx	1	1	SUPPLYING
Cromolyn Sodium Oral Solution (Concentrate) solution, concentrate	rx	1	1	SUPPLYING
Cromolyn Sodium Inhalation Solution solution	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

At a glance

TypeLabeler
Labeler codes76204
Filing names1
Drugs (active)9
Drugs (all time)9
US registrations14
Packages35

Recent events

Shortages, recalls, and registration changes across all filing names.

Jul 21, 2023
RECALLRecall (Class II): Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not…
Oct 25, 2022
SHORTAGEDrug shortage: Albuterol Sulfate Solution (Ritedose Pharmaceuticals, LLC)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.